retatrutide triple agonist weight loss trial New Phase 3 data just dropped 👀 Eli Lilly's reported average approaching 30%, with some patients achieving results historically associated with bariatric surgery. A few important caveats I'm Worried! Triple Agonist GLP-1

And thats not microdosing thats just the art of practicing medicine. Advertisement Sign up for our Health Essentials emails for expert guidance on nutrition, fitness, sleep, skin care and more

Use the retatrutide dosage calculator to plan your complete titration schedule from 1mg through your target maintenance dose

RCT SCALE Study - Liraglutide vs Placebo for Weight Loss in Overweight Nondiabetic Adults, NEJM (2015) [PubMed abstract] The SCALE study enrolled 3731 overweight adults who did not have diabetes Main inclusion criteria BMI 30

Although Hogan et al

The cardiovascular safety demonstrated by tirzepatide in this analysis and SURPASS-4 paved the way for a large-scale cardiovascular outcomes trial

Learn more PT-141 is a revolutionary peptide that has garnered attention for its potential to enhance sexual desire and function